These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9422086

  • 1. Epitope characterization of MUC1 antibodies.
    Imai S, Haga S, Kiyozuka Y.
    Tumour Biol; 1998; 19 Suppl 1():30-4. PubMed ID: 9422086
    [Abstract] [Full Text] [Related]

  • 2. Epitope characterization of MUC1 antibodies.
    Blockzjil A, Nilsson K, Nilsson O.
    Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
    [Abstract] [Full Text] [Related]

  • 3. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Price MR, Rye PD, Petrakou E, Murray A, Brady K, Imai S, Haga S, Kiyozuka Y, Schol D, Meulenbroek MF, Snijdewint FG, von Mensdorff-Pouilly S, Verstraeten RA, Kenemans P, Blockzjil A, Nilsson K, Nilsson O, Reddish M, Suresh MR, Koganty RR, Fortier S, Baronic L, Berg A, Longenecker MB, Hilgers J.
    Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
    [Abstract] [Full Text] [Related]

  • 4. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
    Petrakou E, Murray A, Price MR.
    Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
    [Abstract] [Full Text] [Related]

  • 5. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence.
    Schol DJ, Meulenbroek MF, Snijdewint FG, von Mensdorff-Pouilly S, Verstraeten RA, Murakami F, Kenemans P, Hilgers J.
    Tumour Biol; 1998; 19 Suppl 1():35-45. PubMed ID: 9422087
    [Abstract] [Full Text] [Related]

  • 6. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
    Dai J, Allard WJ, Davis G, Yeung KK.
    Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K, Schol DJ, Snijdewint FG, von Mensdorff-Pouilly S, Poort-Keesom RJ, Karuntu-Wanamarta YA, Verstraeten RA, Miyazaki K, Kenemans P, Hilgers J.
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [Abstract] [Full Text] [Related]

  • 8. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.
    Stigbrand T, Andrés C, Bellanger L, Bishr Omary M, Bodenmüller H, Bonfrer H, Brundell J, Einarsson R, Erlandsson A, Johansson A, Leca JF, Levi M, Meier T, Nap M, Nustad K, Seguin P, Sjödin A, Sundström B, van Dalen A, Wiebelhaus E, Wiklund B, Arlestig L, Hilgers J.
    Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the role of type 1 core O-glycans in the binding of anti-MUC1 antibodies by cytofluorometry and synthetic peptide/glycopeptide binding inhibition studies.
    Reddish MA, Suresh MR, Koganty RR, Fortier S, Baronic L, Berg A, Longenecker BM.
    Tumour Biol; 1998; 19 Suppl 1():57-66. PubMed ID: 9422089
    [Abstract] [Full Text] [Related]

  • 10. Epitope analysis of an immunodominant domain on the P1 protein of Haemophilus influenzae type b using synthetic peptides and anti-idiotypic antibodies.
    Proulx C, Hamel J, Chong P, Martin D, Brodeur BR.
    Microb Pathog; 1992 Jun; 12(6):433-42. PubMed ID: 1522798
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues.
    Cao Y, Karsten U, Hilgers J.
    Tumour Biol; 1998 Jun; 19 Suppl 1():88-99. PubMed ID: 9422093
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1.
    Reis CA, Hassan H, Bennett EP, Clausen H.
    Tumour Biol; 1998 Jun; 19 Suppl 1():127-33. PubMed ID: 9422098
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and antibody recognition of synthetic antigens from MUC1.
    Bánóczi Z, Mezõ G, Windberg E, Uray K, Majer Z, Hudecz F.
    J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847
    [Abstract] [Full Text] [Related]

  • 14. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
    Grinstead JS, Schuman JT, Campbell AP.
    Biochemistry; 2003 Dec 09; 42(48):14293-305. PubMed ID: 14640698
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the carbohydrate specificity of ISOBM TD-4 Workshop anti-MUC1 antibodies.
    Lloyd KO, Kudryashov V.
    Tumour Biol; 1998 Dec 09; 19 Suppl 1():118-21. PubMed ID: 9422096
    [Abstract] [Full Text] [Related]

  • 16. Determination of carbohydrate specificity of monoclonal antibodies against MUC1.
    Galanina OE, Simeoni LA, Ter-Grigoryan AG, Belyanchikov IM, Bovin NV.
    Tumour Biol; 1998 Dec 09; 19 Suppl 1():79-87. PubMed ID: 9422092
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Affinity of antibodies to MUC1 antigens.
    Karanikas V, Patton K, Jamieson G, Pietersz G, McKenzie I.
    Tumour Biol; 1998 Dec 09; 19 Suppl 1():71-8. PubMed ID: 9422091
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop.
    Berger P, Paus E, Hemken PM, Sturgeon C, Stewart WW, Skinner JP, Harwick LC, Saldana SC, Ramsay CS, Rupprecht KR, Olsen KH, Bidart JM, Stenman UH, Members of the ISOBM TD-7 Workshop on hCG and Related Molecules.
    Tumour Biol; 2013 Dec 09; 34(6):4033-57. PubMed ID: 24068570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.